Eli Lilly | LLY - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
AbbVie USD 59M 13M 2025-12
Abbott USD 78M 1000K 2025-12
ALKERMES USD 8.54M 3.59M 2026-03
AstraZeneca USD 73M 62M 2026-03
Baxter International USD 11M 1000K 2025-12
Biogen USD 37.9M 700K 2026-03
Drreddys Laboratories INR 796M 332M 2025-12
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 22M 96M 2026-03
Glaxosmithkline GBP 26M 24M 2025-09
J&J USD 2.14 237M 2026-03
Medtronic USD 114M 23M 2025-01
Merck USD 69M 27M 2025-12
Pfizer USD 115M 51M 2026-03
Phibro Animal Health USD 0.08 0.09 2024-12
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 33M 81M 2025-12
Sanofi EUR 114M 38M 2025-09
United Therapeutics USD 43.2M 3.2M 2025-12
Zoetis USD 25M 1000K 2025-12